Or click and collect!
Or click and collect!
Nicotine has documented effects on blood sugar regulation that are relevant to diabetic vapers, those managing blood sugar through diet and anyone curious about how vaping interacts with metabolism. Here is what the evidence currently shows.
Nicotine has documented effects on blood glucose regulation, primarily through its impact on insulin sensitivity. Research on smokers — who have a substantially higher rate of type 2 diabetes than non-smokers — has identified nicotine as a contributing agent to this elevated risk, independent of other smoking-related factors. Nicotine reduces insulin sensitivity, meaning cells respond less effectively to insulin, leading to higher blood glucose levels in the post-meal period. This effect is relevant for vapers using nicotine-containing products and is of particular significance for those who have diabetes, prediabetes or are managing blood sugar through diet.
Insulin is the hormone that signals cells — primarily muscle and fat cells — to absorb glucose from the bloodstream. Insulin sensitivity describes how effectively cells respond to this signal. Nicotine has been shown to reduce insulin sensitivity through several mechanisms including the stimulation of catecholamine (adrenaline and noradrenaline) release, which promotes glycogen breakdown and opposes insulin's glucose-lowering action. Reduced insulin sensitivity means the body needs to produce more insulin to achieve the same glucose-lowering effect, and in the post-meal period blood glucose remains elevated longer than it would without nicotine. Over time, chronic insulin resistance is a precursor to type 2 diabetes.
Nicotine stimulates cortisol release from the adrenal cortex. Cortisol is a glucocorticoid — it raises blood glucose by stimulating the liver to release stored glucose (glycogenolysis) and by increasing gluconeogenesis (the production of new glucose from amino acids). The cortisol elevation from nicotine use produces a glucose-raising effect that counteracts the glucose-lowering action of insulin. For people with well-controlled type 2 diabetes, this cortisol-mediated glucose elevation can complicate management and lead to unpredictable readings around vaping sessions.
Nicotine's stimulation of adrenaline release produces a glucose-mobilising effect — part of the fight-or-flight physiological response that prepares the body for rapid energy use. Adrenaline signals the liver to release glucose from glycogen stores and inhibits insulin secretion from the pancreas simultaneously. The result is a transient rise in blood glucose following nicotine use. For most healthy non-diabetic vapers this effect is compensated by normal insulin responses without clinical consequence. For those with impaired insulin production or sensitivity, it is more significant.
The metabolic and diabetes risk associated with smoking is substantially driven by nicotine, but combustion products also contribute through oxidative stress and inflammation pathways that independently impair insulin signalling. Vaping removes the combustion contribution to metabolic risk while maintaining the nicotine contribution. This means vaping likely carries a lower overall metabolic risk than smoking but is not metabolically neutral. For diabetic vapers who have switched from cigarettes, this is a harm reduction benefit but not a clean bill of metabolic health.
"We always advise diabetic customers to speak to their diabetes care team about vaping. The blood sugar effects are real and documented — it is not a conversation to avoid."
Touch of Vape team, CoventryIf you have type 1 or type 2 diabetes and vape, your diabetes care team should know. Nicotine's effects on insulin sensitivity and blood glucose can affect your readings and may need to be factored into your management plan. This is not a reason not to vape instead of smoke — it is a reason to manage it with your clinical team's knowledge.
For people with prediabetes or impaired glucose tolerance, nicotine's insulin-sensitising effects add to the metabolic burden of an already compromised system. Reducing or stopping nicotine has clear metabolic benefits alongside its other health advantages. Our Coventry team can advise on step-down options.
If you are having a fasting blood glucose test, vaping before the test may affect the result by elevating blood glucose above the true fasting baseline. Abstaining from vaping for the fasting period before a blood test is advisable.
For people managing blood sugar through diet without a diabetes diagnosis, nicotine's modest insulin-sensitising effect is unlikely to override good dietary practices. However it is worth knowing that nicotine is an active variable in blood sugar regulation and may partially counteract dietary efforts to maintain stable glucose levels.
We take health questions seriously and will always direct you to your GP or specialist for clinical guidance alongside any product advice we can offer.
To find our Coventry store, visit our Vape Shop Coventry page.
Our Health guide covers nicotine's metabolic effects, hormonal impacts and the health questions our Coventry customers ask most frequently.
Find more guides on nicotine, metabolism and health conditions in our Health guide.
We will always point you to your clinical team for medical decisions — and help with everything else.